Physician

Evan Hamilton Fountain, M.D.

According to 2025 Medicare claims, Evan Fountain, M.D. (NPI: 1588046320) practices pulmonary disease in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is COOPERATIVE HEALTHCARE SERVICES INC (NPI: 1417979402; TIN: 010594994) and primary practice location at 31520-4722. Fountain is affiliated with the WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Fountain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 1,599 HCPCS/CPT codes, and received $116,932 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 2,442 prescription claims across 395 beneficiaries totaling $946,750 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,198 claims. Open Payments data shows 170 records totaling $3,796. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $23,180 to $116,932. Similarly, Part D prescription costs have risen steadily, from $1,753 to $946,750. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	128	301	$23,180
2019	47	110	$6,966
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	163	455	$38,051
2023	510	1,678	$119,835
2024	592	1,599	$116,932

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	30	$1,753
2016	51	211	$21,887
2017	32	192	$93,786
2018	37	162	$85,198
2019	19	69	$3,030
2020	15	38	$12,397
2021	18	93	$23,643
2022	101	333	$85,404
2023	283	1,394	$711,114
2024	395	2,442	$946,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	99	569	$68,408
2024	202	1,198	$265,621

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	88	163	$161
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	87	89	$125
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	105	189	$89
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	135	135	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	295	469	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	286	12,030	$252,860
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	132	4,950	$102,500
Fasenra Pen	Benralizumab	12	672	$67,930
Tezspire	Tezepelumab-Ekko	11	308	$50,553
Eliquis	Apixaban	63	2,333	$45,905

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1556	Injection, immune globulin (bivigam), 500 mg	N	N/R	22	$66,617
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	48	$45,206
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$43,481
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	53	$40,421
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	21	$20,639

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	170	$3,796	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Evan Hamilton Fountain, M.D.?

Tedicare shows public-source Medicare data for Evan Hamilton Fountain, M.D. (NPI 1588046320), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Evan Hamilton Fountain, M.D. have ACO affiliation data?

Evan Hamilton Fountain, M.D. is shown with ACO affiliation data for WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Evan Hamilton Fountain, M.D.?

Evan Hamilton Fountain, M.D. is linked to COOPERATIVE HEALTHCARE SERVICES INC (billing NPI 1417979402) in the available physician profile data.

Does Evan Hamilton Fountain, M.D. have Open Payments data?

Evan Hamilton Fountain, M.D. has 170 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.